Labshake search

1 - 10 of 10 citations for Mouse Anti Hepatitis B Virus Core Antibody M412 since 2019

• Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2

  James Brett Case, et al., bioRxiv - Microbiology 2020

  Quote: ... Virus was plaque-purified on Vero CCL81 cells in the presence of 25 μg/ml of cytosine arabinoside (TriLink BioTechnologies), and plaques in agarose plugs were amplified on Vero CCL81 cells ...
• Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA

  Joshua E. McGee, et al., bioRxiv - Bioengineering 2023

  Quote: ... All saRNA templates were generated from a plasmid encoding NSP1-4 of the Venezuela Equine Encephalitis Virus (VEEV) under either a CleanCap AU (TriLink BioTechnologies) compatible T7 promoter (Promoter seq ...
• Extending the dynamic range of biomarker quantification through molecular equalization

  Sharon S. Newman, et al., bioRxiv - Bioengineering 2023

  Quote: dAbs were generated by conjugating amine-modified oligonucleotides (15–25 OD260 units) to polyclonal antibodies (100 µg) using the Antibody-Oligonucleotide All-in-One Conjugation Kit from TriLink Biotechnologies (A-9202) ...
• Continuous detection of glucose and insulin in live animals

  Mahla Poudineh, et al., bioRxiv - Bioengineering 2020

  Quote: ... R-PE antibody conjugation kit was obtained from TriLink Biotechnologies ...
• IFITM3 protects the heart during influenza virus infection

  Adam D. Kenney, et al., bioRxiv - Immunology 2019

  Quote: ... Mouse C57BL/6 zygotes (Taconic) were injected with a mix of Cas9 mRNA (Trilink Biotechnologies) (100 ng/uL ...
• Programmable mammalian translational modulators by CRISPR-associated proteins

  Shunsuke Kawasaki, et al., bioRxiv - Synthetic Biology 2021

  Quote: ... 6 mM Anti Reverse Cap Analog (TriLink BioTechnologies), and the template DNA ...
• Immunopeptidomics-based design of highly effective mRNA vaccine formulations against Listeria monocytogenes

  Rupert L. Mayer, et al., bioRxiv - Immunology 2022

  Quote: ... including an Anti-Reverse Cap Analog (ARCA, Trilink BioTechnologies), and chemically modified N1-methylpseudouridine-5’-triphosphate (Trilink BioTechnologies ...
• Combinatorial CAR design improves target restriction

  Hakan Köksal, et al., bioRxiv - Immunology 2020

  Quote: ... Anti-Reverse Cap Analog (ARCA, Trilink Biotechnologies, San Diego, USA) was used for mRNA capping ...
• Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery

  Tala Shekarian, et al., bioRxiv - Cancer Biology 2022

  Quote: ... carrier-free monoclonal and polyclonal antibodies (Table S2) were conjugated to short DNA oligonucleotides (Trilink Biotechnologies) as described before [4 ...
• mRNA vaccine induces protective immunity against the type III secretory virulence of Pseudomonas aeruginosa

  Ken Kawaguchi, et al., bioRxiv - Immunology 2023

  Quote: ... an anti-reverse capping analogue (Trilink Biotechnologies, San Diego, CA, USA), N1-methylpseudouridine (Sapala Organics Private Limited ...